For a note on the conference at the Healthcare Economist blog by Jason Shafrin, here. For the conference website (including numerous downloadable papers and powerpoints), here.
I've also cut/pasted the conference agenda after the break.
Conference here.
For materials in one zip file (see down arrow to download) here.
NATIONAL BUREAU OF ECONOMIC RESEARCH, INC.
|
Pre-Conference on Economic Dimensions of Personalized and Precision Medicine
|
Supported by USC Schaeffer Center for Health Policy & Economics and Columbia University
|
Ernst Berndt, Dana Goldman, and John Rowe, Organizers
|
September 21-22, 2016
|
The Italian Academy for Advanced Studies in America
Columbia University Library, Third Floor 1161 Amsterdam Avenue New York, NY |
PROGRAM
|
PARTICIPANT LIST
Speakers should expect to present for 15-20 minutes to leave adequate time for discussion.
This time limit will be enforced by the organizers.
Wednesday, September 21: | |
8:45 am
|
Continental Breakfast
|
9:15 am
|
Introductions
|
9:30 am
|
Amitabh Chandra, Harvard University and NBER
Craig Garthwaite, Northwestern University and NBER Ariel Dora Stern, Harvard University Characterizing The Drug Development Pipeline for Precision Therapies |
10:15 am
|
Manuel Hermosilla, Johns Hopkins University
Jorge Lemus, Northwestern University Technological Hype and Innovation: Evidence from the Human Genome |
11:00 am
|
Break
|
11:15 am
|
Philippe Gorry, University of Bordeaux
Empirical Economic Analysis of Orphan Drug Innovation |
12:00 pm
|
Lunch
|
1:00 pm
|
Kristopher Hult, University of ChicagoMeasuring the Potential Health Impact of Personalized Medicine: Evidence from MS Treatments
|
1:45 pm
|
Ernst Berndt, Massachusetts Institute of Technology and NBER
Mark Trusheim, Massachusetts Institute of Technology The Competitive Dynamics of Personalized and Precision Medicine: Insights from Game Theory(background paper) (slides) |
2:30 pm
|
Break
|
2:45 pm
|
Mark Pauly, University of Pennsylvania and NBERCost Sharing in Insurance Coverage for Precision Medicine: Preliminary Notes
|
3:30 pm
|
Tomas Philipson, University of Chicago and NBER
The New Information Economics of Personalized Medicine: Current Findings and Future Research |
4:15 pm
|
Adjourn
|
6:30 pm
|
Dinner
Serafina, 2178 Broadway (at 77th) New York, NY in the NYLO Hotel |
Thursday, September 22:
| |
9:00 am
|
Continental Breakfast
|
9:30 am
|
Frank Lichtenberg, Columbia University and NBER
Rebecca Pulk, Geisinger Health System Marc Williams, Geisinger Health System Eric Wright, Geisinger Health System The Social Cost of Suboptimal Medication Use and the Value of Pharmacogenomic Information: Evidence fromGeisinger Health System |
10:15 am
|
John Graves, Vanderbilt University
Josh Peterson, Vanderbilt University Rational Integration of Genomic Health Care Technology: Evidence from PREDICT |
11:00 am
|
Break
|
11:15 am
|
Guy David, University of Pennsylvania and NBER
Jason Hockenberry, Emory University and NBER David Howard, Emory UniversityPersonalized Medicine in Action: The Case of Intensity Modulated Radiation Therapy |
12:00 pm
|
Lunch
|
1:00 pm
|
Karen Eggleston, Stanford University and NBER
Rachel Jui-f. Lu, Chang Gung University, Taiwan Economic Dimensions of Personalized and Precision Medicine in Taiwan and Korea: Evidence from Breast Cancer Treatment |
1:45 pm
|
Darius Lakdawalla, University of Southern California and NBER
Jason Shafrin, Precision Health EconomicsPredicting Real-World Effectiveness Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework |
2:30 pm
|
Adjourn
|
